Phio Pharmaceuticals
Price & Volume
Stats
See more52W Range | $1.53-$10.35 |
Market Cap | $2M |
Shares Short | 39,760 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$7M |
Diluted EPS | -$14.81 |
News
See moreYahoo Finance • last year
Phio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
Yahoo Finance • last year
Phio Pharmaceuticals Announces First US Patient Enrolled in Phase 1B Clinical Trial with Intratumoral PH-762 anti-PD-1 Therapy for Treatment of Skin Carcinomas
Yahoo Finance • last year
Phio Pharmaceuticals Presents New Data Showing INTASYL Compound targeting CTLA-4 Enhances Tumor Control
About
CEO | Mr. Robert J. Bitterman |
CFO | Mr. Robert M. Infarinato CPA, Esq. |
Address | 11 Apex Drive, Marlborough, MA, United States, 01752 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 8 |
